Matches in SemOpenAlex for { <https://semopenalex.org/work/W2949742418> ?p ?o ?g. }
- W2949742418 endingPage "2304" @default.
- W2949742418 startingPage "2294" @default.
- W2949742418 abstract "Abstract Aims We previously quantified the hypoglycaemia‐sparing effect of portal vs peripheral human insulin delivery. The current investigation aimed to determine whether a bioequivalent peripheral vein infusion of a hepatopreferential insulin analog, insulin‐406, could similarly protect against hypoglycaemia. Materials and methods Dogs received human insulin infusions into either the hepatic portal vein (PoHI, n = 7) or a peripheral vein (PeHI, n = 7) for 180 minutes at four‐fold the basal secretion rate (6.6 pmol/kg/min) in a previous study. Insulin‐406 (Pe406, n = 7) was peripherally infused at 6.0 pmol/kg/min, a rate determined to decrease plasma glucose by the same amount as with PoHI infusion during the first 60 minutes. Glucagon was fixed at basal concentrations, mimicking the diminished α‐cell response seen in type 1 diabetes. Results Glucose dropped quickly with PeHI infusion, reaching 41 ± 3 mg/dL at 60 minutes, but more slowly with PoHI and Pe406 infusion (67 ± 2 and 72 ± 4 mg/dL, respectively; P < 0.01 vs PeHI for both). The hypoglycaemic nadir ( c . 40 mg/dL) occurred at 60 minutes with PeHI infusion vs 120 minutes with PoHI and Pe406 infusion. ΔAUC epinephrine during the 180‐minute insulin infusion period was two‐fold higher with PeHI infusion compared with PoHI and Pe406 infusion. Glucose production (mg/kg/min) was least suppressed with PeHI infusion (Δ = 0.79 ± 0.33) and equally suppressed with PoHI and Pe406 infusion (Δ = 1.16 ± 0.21 and 1.18 ± 0.17, respectively; P = NS). Peak glucose utilization (mg/kg/min) was highest with PeHI infusion (4.94 ± 0.17) and less with PoHI and Pe406 infusion (3.58 ± 0.58 and 3.26 ± 0.08, respectively; P < 0.05 vs Pe for both). Conclusions Peripheral infusion of hepatopreferential insulin can achieve a metabolic profile that closely mimics portal insulin delivery, which reduces the risk of hypoglycaemia compared with peripheral insulin infusion." @default.
- W2949742418 created "2019-06-27" @default.
- W2949742418 creator A5003238102 @default.
- W2949742418 creator A5012339977 @default.
- W2949742418 creator A5013301991 @default.
- W2949742418 creator A5016294176 @default.
- W2949742418 creator A5023772510 @default.
- W2949742418 creator A5027988980 @default.
- W2949742418 creator A5039769087 @default.
- W2949742418 creator A5048059210 @default.
- W2949742418 creator A5059225775 @default.
- W2949742418 creator A5075350597 @default.
- W2949742418 creator A5079801365 @default.
- W2949742418 creator A5083753451 @default.
- W2949742418 creator A5085147613 @default.
- W2949742418 creator A5085997583 @default.
- W2949742418 date "2019-07-08" @default.
- W2949742418 modified "2023-09-26" @default.
- W2949742418 title "Peripherally delivered hepatopreferential insulin analog insulin‐406 mimics the hypoglycaemia‐sparing effect of portal vein human insulin infusion in dogs" @default.
- W2949742418 cites W1969390019 @default.
- W2949742418 cites W1974554536 @default.
- W2949742418 cites W1975369894 @default.
- W2949742418 cites W1976978141 @default.
- W2949742418 cites W1985847165 @default.
- W2949742418 cites W1990200147 @default.
- W2949742418 cites W2005901317 @default.
- W2949742418 cites W2059802140 @default.
- W2949742418 cites W2062806925 @default.
- W2949742418 cites W2097781567 @default.
- W2949742418 cites W2098557641 @default.
- W2949742418 cites W2104246726 @default.
- W2949742418 cites W2106305321 @default.
- W2949742418 cites W2114669482 @default.
- W2949742418 cites W2125430658 @default.
- W2949742418 cites W2142508843 @default.
- W2949742418 cites W2147975094 @default.
- W2949742418 cites W2151479167 @default.
- W2949742418 cites W2154225169 @default.
- W2949742418 cites W2155961449 @default.
- W2949742418 cites W2161399472 @default.
- W2949742418 cites W2162303959 @default.
- W2949742418 cites W2186184337 @default.
- W2949742418 cites W2491328855 @default.
- W2949742418 cites W2530573410 @default.
- W2949742418 cites W2749532988 @default.
- W2949742418 cites W4247078845 @default.
- W2949742418 doi "https://doi.org/10.1111/dom.13808" @default.
- W2949742418 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8132115" @default.
- W2949742418 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31183936" @default.
- W2949742418 hasPublicationYear "2019" @default.
- W2949742418 type Work @default.
- W2949742418 sameAs 2949742418 @default.
- W2949742418 citedByCount "6" @default.
- W2949742418 countsByYear W29497424182020 @default.
- W2949742418 countsByYear W29497424182021 @default.
- W2949742418 countsByYear W29497424182022 @default.
- W2949742418 countsByYear W29497424182023 @default.
- W2949742418 crossrefType "journal-article" @default.
- W2949742418 hasAuthorship W2949742418A5003238102 @default.
- W2949742418 hasAuthorship W2949742418A5012339977 @default.
- W2949742418 hasAuthorship W2949742418A5013301991 @default.
- W2949742418 hasAuthorship W2949742418A5016294176 @default.
- W2949742418 hasAuthorship W2949742418A5023772510 @default.
- W2949742418 hasAuthorship W2949742418A5027988980 @default.
- W2949742418 hasAuthorship W2949742418A5039769087 @default.
- W2949742418 hasAuthorship W2949742418A5048059210 @default.
- W2949742418 hasAuthorship W2949742418A5059225775 @default.
- W2949742418 hasAuthorship W2949742418A5075350597 @default.
- W2949742418 hasAuthorship W2949742418A5079801365 @default.
- W2949742418 hasAuthorship W2949742418A5083753451 @default.
- W2949742418 hasAuthorship W2949742418A5085147613 @default.
- W2949742418 hasAuthorship W2949742418A5085997583 @default.
- W2949742418 hasBestOaLocation W29497424182 @default.
- W2949742418 hasConcept C126322002 @default.
- W2949742418 hasConcept C134018914 @default.
- W2949742418 hasConcept C2775859304 @default.
- W2949742418 hasConcept C2778024521 @default.
- W2949742418 hasConcept C2778563252 @default.
- W2949742418 hasConcept C2779033008 @default.
- W2949742418 hasConcept C2779306644 @default.
- W2949742418 hasConcept C2780668416 @default.
- W2949742418 hasConcept C46762472 @default.
- W2949742418 hasConcept C71924100 @default.
- W2949742418 hasConceptScore W2949742418C126322002 @default.
- W2949742418 hasConceptScore W2949742418C134018914 @default.
- W2949742418 hasConceptScore W2949742418C2775859304 @default.
- W2949742418 hasConceptScore W2949742418C2778024521 @default.
- W2949742418 hasConceptScore W2949742418C2778563252 @default.
- W2949742418 hasConceptScore W2949742418C2779033008 @default.
- W2949742418 hasConceptScore W2949742418C2779306644 @default.
- W2949742418 hasConceptScore W2949742418C2780668416 @default.
- W2949742418 hasConceptScore W2949742418C46762472 @default.
- W2949742418 hasConceptScore W2949742418C71924100 @default.
- W2949742418 hasIssue "10" @default.
- W2949742418 hasLocation W29497424181 @default.
- W2949742418 hasLocation W29497424182 @default.
- W2949742418 hasOpenAccess W2949742418 @default.
- W2949742418 hasPrimaryLocation W29497424181 @default.